Advances in treatment of migraine

A tétel rövid nézete
dc.contributor.advisorPórszász, Róbert
dc.contributor.advisordeptDebreceni Egyetem::Általános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézethu_HU
dc.contributor.authorAlghamdi, Waleed
dc.contributor.departmentDE--Általános Orvostudományi Karhu_HU
dc.contributor.opponentSzentmiklósi, József András
dc.contributor.opponentDrimba, László
dc.contributor.opponentdeptDebreceni Egyetem::Általános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézethu_HU
dc.contributor.opponentdeptKenézy Kórház Központi Aneszteziológiai és Intenzív Terápiás Osztályhu_HU
dc.date.accessioned2019-01-30T09:33:41Z
dc.date.available2019-01-30T09:33:41Z
dc.date.created2018-06-22
dc.description.abstractMigraine headache is a widespread neurovascular disorder that is often inadequately treated by existing medical therapies, resulting in a population of patients with significant residual disability. Treatment strategies include educational interventions, lifestyle modifications, and trigger management, as well as acute and preventive pharmacotherapy. Objectives: the aim of this work is to identify the advances in treatment of migraine.We found that the most famous drug used in migraine treatment is triptan. And found also that most of patients are non-responsive to a triptan at 2 h after treatment onset, or do not tolerate existing acute treatment options, including triptans.So new drugs are discovered for treatment of migraine like CGRP, Serotonin 5HT1F agonists, Glutamate receptor antagonists, etc.hu_HU
dc.description.correctorSZG
dc.description.courseáltalános orvoshu_HU
dc.description.courselangangolhu_HU
dc.description.degreeegységes, osztatlanhu_HU
dc.format.extent51hu_HU
dc.identifier.urihttp://hdl.handle.net/2437/263364
dc.language.isoenhu_HU
dc.subjectmigrainehu_HU
dc.subjecttriptan
dc.subjectCGRP
dc.subject.dspaceDEENK Témalista::Orvostudomány::Farmakológiahu_HU
dc.titleAdvances in treatment of migrainehu_HU
Fájlok
Gyűjtemények
Theses (Faculty of Medicine)